HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HSTM

HealthStream, Inc. (NASDAQ)

Healthcare — Health Information Services

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Buy 2.2 / 5 2 analysts
$26.89
$-0.95 (-3.41%)
Target: $32.00 (19.0%)
Sign in to add HSTM to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$826.21M
P/E Ratio (TTM)42.21
Forward P/E32.69
EPS (TTM)$0.67
Dividend Yield0.47%
Profit Margin6.39%
Revenue Growth10.50%
ROE5.57%
Debt/Equity4.00
Recommendation Buy 2.2
Analyst Target$32.00
Analysts2
Indexes NASDAQ

Technical Indicators

RSI (14)69.1
Beta0.47
SMA 20-
SMA 40-
52-Week High$29.63
52-Week Low$19.50
50-Day Avg$24.23
200-Day Avg$23.68
Avg Volume232.3K
Volume226.7K

Performance Analysis

BULLISH

HSTM shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 73% of its 52-week range.
+ RSI at 69.1 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 42.2 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 10.5% year-over-year.
+ Wall Street consensus is "Buy" from 2 analysts.
+ Average analyst target of $32.00 implies 19.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:14 UTC

Back to Screener Export Report